dapsone has been researched along with Pneumocystis Infections in 22 studies
Pneumocystis Infections: Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of P carinii infection presenting as bilateral aural polyps, otitis media and mastoiditis in human immunodeficiency (HIV)-positive patient with no history of prior or concomitant P carinii infection." | 2.41 | Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient. ( Elmahallawy, M; Horsfield, C; Praveen, CV; Terry, RM, 2002) |
| "Dapsone was discontinued with resolution of all symptoms." | 1.35 | Didactic lessons from the serum lactate dehydrogenase posttransplant: a clinical vignette. ( Boothpur, R; Brennan, DC, 2008) |
| " Extending these experiments, we have now shown that roxithromycin at doses of 400 or 200 mg/kg/day combined with dapsone at doses of 5, 25 or 50 mg/kg/day completely prevented the development of T." | 1.30 | Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. ( Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mack, J | 1 |
| Mian, A | 1 |
| Roxby, A | 1 |
| Jain, R | 1 |
| Kumar, MS | 1 |
| Sierka, DR | 1 |
| Damask, AM | 1 |
| Fyfe, B | 1 |
| McAlack, RF | 1 |
| Heifets, M | 1 |
| Moritz, MJ | 1 |
| Alvarez, D | 1 |
| Kumar, A | 1 |
| Sangiolo, D | 1 |
| Storer, B | 1 |
| Nash, R | 1 |
| Corey, L | 1 |
| Davis, C | 1 |
| Flowers, M | 1 |
| Hackman, RC | 1 |
| Boeckh, M | 1 |
| Talarico, JF | 1 |
| Metro, DG | 1 |
| Dunford, LM | 1 |
| Roy, DM | 1 |
| Hahn, TE | 1 |
| Padmanabhan, S | 1 |
| Segal, BH | 1 |
| Almyroudis, N | 1 |
| McCarthy, PL | 1 |
| Battiwalla, M | 1 |
| Boothpur, R | 1 |
| Brennan, DC | 1 |
| Mahlakwane, MS | 1 |
| Ramdial, PK | 1 |
| Sing, Y | 1 |
| Calonje, E | 1 |
| Biyana, S | 1 |
| Mehlhorn, H | 1 |
| Dankert, W | 1 |
| Hartman, PG | 1 |
| Then, RL | 1 |
| Hughes, WT | 1 |
| Killmar, JT | 1 |
| Oz, HS | 1 |
| Brun-Pascaud, M | 3 |
| Chau, F | 3 |
| Simonpoli, AM | 1 |
| Girard, PM | 3 |
| Derouin, F | 3 |
| Pocidalo, JJ | 1 |
| Podzamczer, D | 1 |
| Martos, A | 1 |
| Ferrer, I | 1 |
| Santin, M | 1 |
| Gudiol, F | 1 |
| Garry, L | 1 |
| Jacobus, D | 1 |
| Bundow, DL | 1 |
| Aboulafia, DM | 1 |
| Ruggli, GM | 1 |
| Weber, R | 1 |
| Messmer, EP | 1 |
| Font, RL | 1 |
| Moll, C | 1 |
| Bernauer, W | 1 |
| Fishman, JA | 1 |
| Ioannidis, JP | 1 |
| Dixon, DO | 1 |
| McIntosh, M | 1 |
| Albert, JM | 1 |
| Bozzette, SA | 1 |
| Schnittman, SM | 1 |
| Patel, SK | 1 |
| Philpott, JM | 1 |
| McPartlin, DW | 1 |
| Vasconcelles, MJ | 1 |
| Bernardo, MV | 1 |
| King, C | 1 |
| Weller, EA | 1 |
| Antin, JH | 1 |
| Praveen, CV | 1 |
| Terry, RM | 1 |
| Elmahallawy, M | 1 |
| Horsfield, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection[NCT00000991] | Phase 3 | 600 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dapsone and Pneumocystis Infections
| Article | Year |
|---|---|
Skin involvement with Pneumocystis despite dapsone prophylaxis: a rare cause of skin nodules in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Dermatomycoses; Humans | 1997 |
Treatment of infection due to Pneumocystis carinii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans | 1998 |
An unusual case of Pneumocystis carinii presenting as an aural mass.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Drug Therapy, Combinat | 1999 |
Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Ear Neoplasms; Ear, Middle | 2002 |
1 trial available for dapsone and Pneumocystis Infections
| Article | Year |
|---|---|
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Ma | 2000 |
17 other studies available for dapsone and Pneumocystis Infections
| Article | Year |
|---|---|
Case 5: Fever and Hypoxia in a 17-year-old Boy Undergoing Cancer Chemotherapy.
Topics: Adolescent; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Dapsone; Fever; H | 2017 |
Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient.
Topics: Blood Glucose; Burkitt Lymphoma; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Dapsone | 2013 |
Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.
Topics: AIDS-Associated Nephropathy; Candidiasis, Oral; Dapsone; Female; Graft Rejection; HIV Seropositivity | 2005 |
Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Case-Control Studies; Child; Child, Preschool; Dapso | 2005 |
Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant.
Topics: Adolescent; Anesthesia, General; Anti-Infective Agents; Dapsone; Folic Acid Antagonists; Humans; Int | 2005 |
Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Dapsone; Female; Hematopoietic Stem Cell Transplanta | 2006 |
Didactic lessons from the serum lactate dehydrogenase posttransplant: a clinical vignette.
Topics: Anti-Infective Agents; Biomarkers; Dapsone; Female; Humans; Kidney Transplantation; L-Lactate Dehydr | 2008 |
Otic pneumocystosis in acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Drug Therapy, Combinat | 2008 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; F | 1995 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Tria | 1994 |
Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Brain; Dapsone; Drug Therapy, Combinat | 1994 |
Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Humans; Liver Dise | 1993 |
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid | 1996 |
Pneumocystis carinii infection of the conjunctiva in a patient with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Conjunctiva; Conjunctival Disea | 1997 |
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Respons | 1998 |
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Controlled Clinical Trials as Topic; D | 1999 |